Edition:
United Kingdom

SCYNEXIS Inc (SCYX.OQ)

SCYX.OQ on NASDAQ Stock Exchange Global Market

1.25USD
21 Sep 2018
Change (% chg)

$-0.04 (-2.73%)
Prev Close
$1.28
Open
$1.28
Day's High
$1.28
Day's Low
$1.25
Volume
11,034
Avg. Vol
76,584
52-wk High
$2.50
52-wk Low
$1.05

Chart for

About

SCYNEXIS, Inc. is engaged in the discovery, development and commercialization of anti-infectives. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of several fungal infections, including serious invasive fungal infections. SCY-078 is a structurally distinct... (more)

Overall

Beta: 0.40
Market Cap(Mil.): $65.20
Shares Outstanding(Mil.): 26.72
Dividend: --
Yield (%): --

Financials

  SCYX.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.98 -- --
ROI: -49.38 15.07 14.61
ROE: -62.87 16.59 16.33

BRIEF-Scynexis Q1 Loss Per Share $0.12

* SCYNEXIS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE

08 May 2018

Earnings vs. Estimates